Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a ...

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

Market OverviewThe global allergy diagnostics market is expected to witness strong growth at a compound annual growth rate of ...

A Scottish health charity is urging politicians to make respiratory health a priority ahead of the May elections. Approximately 720,000 people have asthma in Scotland and a further 241,000 are ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.